Clinically and statistically significant reductions in peripheral neuropathy were seen following neurofeedback.
Spinal cord stimulation using precision approach via 3D neural targeting shows superior efficacy in treating chronic axial low back pain compared with a trial-and-error method to achieve desired paresthesia.
New evidence on diabetic neuropathy has emerged since the ADA's last published a position statement in 2005.
A significant decrease in migraine frequency was observed, but it is not clear how large a role placebo effect plays in treatment response.
Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.
The recommendations promote the use of hot compresses and physical therapy as first-line treatment of low back pain.
Nearly half of seniors taking these drug combinations didn't have a formal diagnosis of a mental health condition, insomnia, or pain condition.
New research suggests that opioid addiction may be linked to a genetic variant, and more personalized treatment may help those with the change.
Interventions with clinical massage or guided imagery may help ease pain and anxiety in patients in a progressive care unit.
The abuse of opioids or other substances may cause short-term amnesia.
Patients with successful spinal cord stimulation implants had significantly reduced opioid use 1 year post-implant.
Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.
The new guidelines offer guidance on dosing, including reduced starting and maintenance dosing and safety precautions for diagnosing and treating complications.
The FDA instituted widespread updates to product labeling for opioid medications in December, 2016.
While likely a placebo effect, spinal manipulation may be an option for patients with migraine refractory to treatment.
Rates of severe pain were significantly higher in veterans with back and jaw pain, severe headaches or migraine, and neck pain.
The US FDA is requiring that label changes be made to reflect the risks involved with extended exposure to anesthetics and sedatives in children and pregnant women.
Even a single occurrence of emotional abuse during childhood predisposes an individual to migraine.
Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.
Recent findings offer a new avenue for the development of peripheral analgesics with minimal adverse effects.
The guidelines were developed by a group of RLS experts from the US and Europe who utilized the American Academy of Neurology's 2004 guideline development manual.
After treatment, there were marked decreases in visual analog scale (VAS)-pain, VAS-asthenia, severity of waking unrefreshed, tender point count, and Beck Depression Inventory.
Recovery time varies depending on which class of medication the patient is overusing.
The researchers observed a 47.5% increase in the percentage of participants who had a final pain score of 4 or less out of 10.
Diabetes, waist circumference, and prediabetes were the main metabolic factors associated with neuropathy.
Even after loss of exclusivity, pregabalin has lower health care costs than gabapentin.
The group developed the algorithm through a year-long process of reviewing relevant published data.
Kratom may be used to develop nonaddictive alternatives to opioids.
Alternative treatments include endomorphins, spinal cord stimulation, and psychotherapy.
Novice prescribers cited insufficient access to substance abuse counseling for patients, as well as insufficient access to more experienced prescribers, as reasons for not treating more patients.
Neurology Advisor Articles
- New Sleep Apnea Clinical Practice Guidelines
- International League Against Epilepsy Updates Epilepsy Classification System
- In Refractory Status Epilepticus, Lacosamide May Be a Good Option
- Patent Foramen Ovale Closure Reduces Stroke Risk in Patients With Inherited Thrombophilias
- The Handoff: Your Week in Neurology News - 3/23/17